Researchers from Ohio State University, led by Distinguished Professor John J. Coccyx and graduate student Arshad Ahmad from Heritage College of Osteopathic Medicine have discovered a potential new ...

February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.

The global oncology market is projected to nearly triple from $279.98 billion in 2026 to an estimated $748.17 billion by 2035 ...

Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced ...

SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments ...

West Yorkshire health leaders welcome new national cancer plan but warn delivery will be ‘crucial’ for families.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

The FDA granted accelerated approval to Boehringer Ingelheim’s Hernexeos for first-line HER2-mutant NSCLC following a 44-day ...

A phase 3 global trial is enrolling previously treated locally advanced/metastatic nonsquamous NSCLC to define DATROWAY efficacy and safety at scale. IDE034 is in open-label phase 1 ...

Modelling indicates that over a 20-year period, a national screening programme could detect around 9,000 lung cancers and potentially save more than 6,000 lives – an estimated 300 lives each year.

Radiation therapy is a cornerstone of lung cancer treatment. But even when delivered with precision, radiation can damage healthy lung tissue. "Try as we might, when we deliver radiation to a cancer, ...